VIRI logo

Virios Therapeutics, Inc. Common Stock


VIRI: Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia.


Show VIRI Financials

Consumer Interest
SEC Filings

Recent trades of VIRI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VIRI's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Valaciclovir and celecoxib combination for functional somatic syndromes Aug. 24, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of VIRI in WallStreetBets Daily Discussion


Recent insights relating to VIRI

CNBC Recommendations

Recent picks made for VIRI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VIRI

Corporate Flights

Flights by private jets registered to VIRI